Simeon Kimmel, MD, MA

Assistant Professor, Medicine

Simeon Kimmel
617.414.2846
801 Massachusetts Avenue

Biography

Simeon Kimmel is an Assistant Professor of Medicine at Chobanian and Avedisian School of Medicine and an Attending Physician in the Sections of General Internal Medicine and Infectious Diseases at Boston Medical Center and Medical Director of Project TRUST, Boston Medical Center’s harm reduction focused drop-in center. He trained in Internal Medicine and Primary Care at Brigham and Women’s Hospital before completing a joint fellowship in Addiction Medicine and Infectious Diseases at Boston Medical Center. He also earned a Master’s Degree in Medical Anthropology from the Harvard Graduate School of Arts and Sciences. His research focuses on improving retention in treatment with medications for opioid use disorder following serious injection related infections as well as the integration of addiction and harm reduction services with infectious disease care. He was awarded a Career Development Award from NIDA in 2021.

Other Positions

  • Faculty, Clinical Addiction Research and Education Unit, Medicine, Boston University Chobanian & Avedisian School of Medicine

Education

  • Harvard Medical School, MD
  • Harvard Graduate School of Arts and Sciences, MA

Publications

  • Published on 1/28/2025

    Benheim TS, Kimmel SD, George M, Dow PM. Readmissions and Mortality After "Before Medically Advised" Hospital Discharges Among Medicare Beneficiaries with Opioid Use Disorder. J Gen Intern Med. 2025 Jan 28. PMID: 39875771.

    Read at: PubMed
  • Published on 12/17/2024

    Bovell-Ammon BJ, Onofrey S, Kimmel SD, Wurcel AG, Klevens M. Incarceration history and HIV testing among people who inject drugs in the Boston metro area: a pooled cross-sectional study. Res Sq. 2024 Dec 17. PMID: 39764124.

    Read at: PubMed
  • Published on 11/8/2024

    Rosenmoss S, LaRochelle M, Bearnot B, Weinstein Z, So-Armah K, Moyo P, Yan S, Walley AY, Kimmel SD. Racial and Ethnic Disparities in Referral Rejection from Postacute Care Facilities among People with Opioid Use Disorder in Massachusetts. J Addict Med. 2024 Nov 08. PMID: 39514897.

    Read at: PubMed
  • Published on 10/8/2024

    Nishar S, Soske J, Vanjani R, Kimmel SD, Roma C, Dow PM. Access and care for people with opioid use disorder in U.S. skilled nursing facilities: A policy commentary. Int J Drug Policy. 2024 Nov; 133:104607. PMID: 39383611.

    Read at: PubMed
  • Published on 8/1/2024

    Christine PJ, Chahine RA, Kimmel SD, Mack N, Douglas C, Stopka TJ, Calver K, Fanucchi LC, Slavova S, Lofwall M, Feaster DJ, Lyons M, Ezell J, Larochelle MR. Buprenorphine Prescribing Characteristics Following Relaxation of X-Waiver Training Requirements. JAMA Netw Open. 2024 Aug 01; 7(8):e2425999. PMID: 39102264.

    Read at: PubMed
  • Published on 7/30/2024

    Parbs JR, Srinivasan S, Pustz J, Bayly R, Shrestha S, Lewis O, Kimmel S, Meehan T, Babakhanlou-Chase H, Stopka TJ. The optimization of harm reduction services in Massachusetts through the use of GIS: Location-allocation analyses, 2019-2021. Prev Med. 2024 Sep; 186:108088. PMID: 39084414.

    Read at: PubMed
  • Published on 7/12/2024

    Paradise RK, Bazzi AR, Clarke J, Desmarais J, Hoyos-Cespedes A, Nurani A, O'Malley SE, Taylor S, Walley AY, Dooley D, Kimmel SD. Multilevel Factors Impacting Substance Use Treatment Access, Engagement, and Racial Equity Among Opioid Overdose Survivors in Boston, MA. J Gen Intern Med. 2024 Oct; 39(13):2390-2399. PMID: 38997532.

    Read at: PubMed
  • Published on 7/1/2024

    Kimmel SD, Walley AY, White LF, Yan S, Grella C, Majeski A, Stein MD, Bettano A, Bernson D, Drainoni ML, Samet JH, Larochelle MR. Medication for Opioid Use Disorder After Serious Injection-Related Infections in Massachusetts. JAMA Netw Open. 2024 Jul 01; 7(7):e2421740. PMID: 39046742.

    Read at: PubMed
  • Published on 4/24/2024

    Idrisov B, Van Draanen J, Lodi S, Lunze K, Kimmel SD, Quinn EK, Truong V, Blokhina E, Gnatienko N, Krupitsky E, Samet JH, Williams EC. Socioeconomic Status and CD4 Count Among People with HIV Who Inject Drugs in St. Petersburg, Russia. AIDS Behav. 2024 Jul; 28(7):2239-2246. PMID: 38658481.

    Read at: PubMed
  • Published on 4/24/2024

    Fletcher L, Burrowes S, Sabin LL, McCann N, Khan GK, Ruiz-Mercado G, Johnson S, Kimmel SD, Pierre C, Drainoni ML. Long-Acting Injectable ART in Practice: A Mixed Methods Implementation Study Assessing the Feasibility of Using LAI ART in High Risk Populations and At Alternative Low Barrier Care Sites. AIDS Patient Care STDS. 2024 May; 38(5):221-229. PMID: 38656905.

    Read at: PubMed

View 49 more publications: View full profile at BUMC

View all profiles